ARATANA THERAPEUTICS, INC.
ARATANA THERAPEUTICS, INC. (PETX) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 197 transactions totaling $79.9M, demonstrating a bearish sentiment with -$55.8M in net insider flow. The most recent transaction on Jul 18, 2019 involved a transaction of 129,889 shares valued at $0.
PETX Insider Activity Summary
Who Is Buying PETX Stock?
No significant insider buying has been recorded for PETX in the recent period.
Who Is Selling PETX Stock?
No significant insider selling has been recorded for PETX in the recent period.
Is ARATANA THERAPEUTICS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PETX is bearish with an Insider Alignment Score of 15/100 and a net flow of -$55.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PETX Frequently Asked Questions
Understanding PETX Insider Activity
Insider trading at ARATANA THERAPEUTICS, INC. (PETX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading PETX stock, having executed 197 transactions in the past 90 days. The most active insider is Jay Lichter (Executive), who has made 4 transactions totaling $18.7M.
Related Tools
Track ARATANA THERAPEUTICS, INC. Insider Activity
Get notified when executives and directors at PETX file new Form 4 transactions